Dactinomycin, Injection | ||||
CAS NO.: | 50-76-0 | |||
Chemical Formula: | C62H86N12O16 | |||
Molecular Weight: | 1255.4000 | |||
DMF&GMP status: | Please contact us for more details. | Description: |
Mechanism of Action
Dactinomycin for injection is a cytotoxic actinomycin that binds DNA and inhibits RNA synthesis. The cytotoxic activity of dactinomycin has been demonstrated in animal models of different human cancers. Pharmacodynamics Dactinomycin exposure-response relationships and the time course of pharmacodynamics response are unknown. Pharmacokinetics The distribution and excretion of radiolabeled dactinomycin ( 3H actinomycin D) were assessed in three adult patients with malignant melanoma. Drug Interaction Studies Published in vitro studies report that dactinomycin may be a substrate of the P-glycoprotein and OATP1B3 transporter systems. **Please noted, we do not sell medicines to Individuals. Our products are for Pharmaceutical Companies, Wholesalers, Research Organization and Institutes. A safe online Medicine store should have License by the state board of pharmacy, have a licensed pharmacist, require a prescription and more. For instructions about how to purchase the medicines online, please review FDA official website. |
|
Approvals | ||||
Active Ingredient | Dosage Form; Route | Strength | Proprietary Name | Applicant |
DACTINOMYCIN | INJECTABLE;INJECTION | Please contact us for more details | Please contact us for more details | Please contact us for more details |
Patent Data | ||||
Patent No. | Patent Expiration | Drug Substance Claim | Drug Product Claim | Patent Use Code |
N.A. | N.A. | N.A. | N.A. | N.A. |
Exclusive Data | ||||
Exclusivity Code | Exclusivity Expiration | |||
N.A. | N.A. | |||